113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

37 trials found

diseases per page:

Showing 1 to 10 of 37 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-000602-10-BG (EUCTR)	10/03/2020	07/01/2020	A clinical study to assess how effective and safe is idebenonetreatment in patients with Duchenne Mu ...	A Phase III Double-blind, Randomized, Placebo-Controlled Study assessing the Efficacy, Safety and To ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;Spain;Ireland;Austria;Israel;United Kingdom;Italy;Switzerland;France;Hungary;Belgium;B ...
2	EUCTR2017-004279-30-NL (EUCTR)	23/01/2020	16/05/2018	A clinical study to assess the long-term safety and efficacy of idebenonetreatment in patients with ...	A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenonein Pa ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;France;Spain;Belgium;Austria;Israel;Germany;Netherlands;United Kingdom;Switzerland;Ita ...
3	EUCTR2017-004279-30-AT (EUCTR)	15/02/2019	04/01/2019	A clinical study to assess the long-term safety and efficacy of idebenonetreatment in patients with ...	A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenonein Pa ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;France;Spain;Belgium;Austria;Israel;Netherlands;Germany;United Kingdom;Switzerland;Ita ...
4	EUCTR2017-004279-30-ES (EUCTR)	21/12/2018	16/11/2018	A clinical study to assess the long-term safety and efficacy of idebenonetreatment in patients with ...	A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenonein Pa ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;France;Belgium;Spain;Austria;Israel;Netherlands;Germany;United Kingdom;Switzerland;Ita ...
5	EUCTR2016-000602-10-HU (EUCTR)	18/12/2018	05/11/2018	A clinical study to assess how effective and safe is idebenonetreatment in patients with Duchenne Mu ...	A Phase III Double-blind, Randomized, Placebo-Controlled Study assessing the Efficacy, Safety and To ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;Spain;Ireland;Austria;Israel;United Kingdom;Italy;Switzerland;France;Hungary;Belgium;B ...
6	EUCTR2017-004279-30-GB (EUCTR)	26/10/2018	09/05/2018	A clinical study to assess the long-term safety and efficacy of idebenonetreatment in patients with ...	A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenonein Pa ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;France;Spain;Belgium;Austria;Israel;Netherlands;Germany;Switzerland;Italy;United Kingd ...
7	EUCTR2017-004279-30-IT (EUCTR)	29/08/2018	22/01/2021	A clinical study to assess the long-term safety and efficacy of idebenonetreatment in patients with ...	A Phase III Open-Label Extension Study to Assess the Long-Term Safetyand Efficacy of Idebenonein Pat ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone Product Code: [Idebenone] INN or Proposed INN: IDEBENONE	SANTHERA PHARMACEUTICALS	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	France;United States;Spain;Belgium;Austria;Israel;Netherlands;Germany;United Kingdom;Switzerland;Ita ...
8	NCT03603288 (ClinicalTrials.gov)	July 4, 2018	31/5/2018	Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)	A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenonein Pa ...	Duchenne Muscular Dystrophy	Drug: idebenone 150 mg film-coated tablets	Santhera Pharmaceuticals	NULL	Terminated	11 Years	N/A	Male	161	Phase 3	United States;Austria;Belgium;France;Germany;Italy;Spain;Switzerland;United Kingdom
9	EUCTR2017-004279-30-BE (EUCTR)	14/06/2018	04/05/2018	A clinical study to assess the long-term safety and efficacy of idebenonetreatment in patients with ...	A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenonein Pa ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;France;Spain;Belgium;Austria;Israel;Netherlands;Germany;United Kingdom;Switzerland;Ita ...
10	EUCTR2016-000602-10-NL (EUCTR)	26/04/2017	20/09/2016	A clinical study to assess how effective and safe is idebenonetreatment in patients with Duchenne Mu ...	A Phase III Double-blind, Randomized, Placebo-Controlled Study assessing the Efficacy, Safety and To ...	Duchenne Muscular Dystrophy (DMD) MedDRA version: 20.0;Level: PT;Classification code 10013801;Term: ...	Trade Name: Raxone Product Name: Idebenone INN or Proposed INN: IDEBENONE Other descriptive name: IDEBE ...	Santhera Pharmaceuticals (Switzerland) Limited	NULL	Not Recruiting			Female: no Male: yes	266	Phase 3	United States;Spain;Ireland;Austria;Israel;Italy;Switzerland;United Kingdom;France;Hungary;Belgium;B ...

First Previous1 2 3 4Next Last